Abstract
The Global Parkinson's Genetics Program (GP2) is an international collaborative program that focuses on improving our understanding of the role of genetics in Parkinson's disease (PD) and on making this knowledge globally available and actionable. The “Monogenic Hub” aims to perform both short and long-read whole-genome sequencing (WGS) for a total of 10.000 PD patients starting with a 500-genomes pilot project, with the goal of identifying novel monogenic causes of PD.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call